Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Lycia Therapeutics announced it raised $75 Million in an initial filing from an offering of $75 Million
Amount Raised
$75 Million
Round Type
Series D
San FranciscoBiotechnologyInvestors
Description
Lycia Therapeutics, based in South San Francisco, California, raised $75m in Series D funding. The round was co-led by Janus Henderson Investors and Balyasny Asset Management, with participation from various investors. The funds will be used to advance its lead cataLYTAC pipeline programs for food allergy and Graves’ disease. The company's leadership has recently strengthened its corporate governance.
Fundz sees it the moment Lycia Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lycia Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.